| Wellcare West Virginia Medicare Clinical | Allogeneic Hematopoietic Progenitor Cell Therapy | 2026-01-01 |
| Wellcare Wisconsin Medicare Clinical | Medical Necessity Criteria | 2026-01-01 |
| Wellcare Wisconsin Medicare Clinical | Allogeneic Hematopoietic Progenitor Cell Therapy | 2026-01-01 |
| Wellcare Wyoming Medicare Clinical | Medical Necessity Criteria | 2026-01-01 |
| Wellcare Wyoming Medicare Clinical | Allogeneic Hematopoietic Progenitor Cell Therapy | 2026-01-01 |
| Ambetter Health North Carolina Clinical | Concert Genetic Testing: Multisystem Genetic Conditions | 2026-01-01 |
| Ambetter Health Texas Superior Medicaid Clinical | POLICYTITLE | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Category III Codes | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Dexamethasone Intracanalicular Ophthalmic Insert (Dextenza®) | 2026-01-01 |
| BCBS Highmark Delaware | External Hearing Aids, Auditory Brainstem Implant, Bone-Anchored Hearing Devices and Audiological Testing | 2026-01-01 |